PRECISION ONCOLOGY CONNECT is an international group of experts in the field of detection and treatment of targetable genetic/genomic alterations in various cancers, and is an initiative of COR2ED. The group discusses the latest scientific and clinical insights, identifies educational needs, and develops educational programmes to support healthcare professionals globally to provide the best possible care to their patients
Previously known as NTRK CONNECT, this site was updated to PRECISION ONCOLOGY CONNECT in January 2023
PRECISION ONCOLOGY CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from AstraZeneca and Bayer.
What’s new from PRECISION ONCOLOGY CONNECT
Conference update
-
Downloadable
Resources -
03 MIN
-
Jul 2024
Podcast
An Introduction to Molecular Testing
Listen to PRECISION ONCOLOGY CONNECT experts in conversation
Experts
Dr Tracy L Stockley, Prof. David Hong-
Downloadable
Resources -
24 MIN
-
Jul 2023
Video
Conference Update: ASCO and WCGIC 2023
An expert perspective on the latest data in precision oncology
Experts
Prof. Andrea Sartore-Bianchi-
Downloadable
Resources -
5 MIN
-
Jul 2023
Diagnosis and Treatment of TRK Fusion-Positive Lung Cancer
How will your clinical decisions impact a patient at two key stages in their journey?
Experts
Prof. Fernando López-Ríos, Prof. Mark Socinski-
60 MIN
-
May 2023
Current perspectives on TRK fusion-positive thyroid cancers
Clinical summary video and slides
Experts
Prof. Ezra Cohen-
Downloadable
Resources -
5 MIN
-
Dec 2022
Episode
3
of 3
TRK fusion-positive cancer poster tour at ESMO 2022 – 3
Poster 3: Moreno V. et al (WCLC 2022)
Experts
Prof. David Hong-
2 MIN
-
Oct 2022